Skip to search formSkip to main contentSkip to account menu

HDAC Inhibitor CHR-3996

Known as: Histone Deacetylase Inhibitor CHR-3996 
An orally bioavailable, second-generation hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. HDAC… 
National Institutes of Health

Search for papers about HDAC Inhibitor CHR-3996

Search papers